Clinical Trial Detail

NCT ID NCT01829217
Title Sunitinib in Never-Smokers With Lung Adenocarcinoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Dana-Farber Cancer Institute
Indications

lung non-small cell carcinoma

Therapies

Sunitinib

Age Groups: adult

Additional content available in CKB BOOST